RXO, Inc. (NYSE:RXO) Receives $26.47 Consensus Price Target from Analysts

Shares of RXO, Inc. (NYSE:RXOGet Free Report) have been given an average recommendation of “Hold” by the seventeen research firms that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $26.27.

Several brokerages have weighed in on RXO. Benchmark reissued a “hold” rating on shares of RXO in a research note on Tuesday, October 15th. Citigroup downgraded RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price on the stock. in a research report on Tuesday, November 12th. Susquehanna decreased their price target on RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research note on Tuesday, November 12th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $29.00 price objective on shares of RXO in a research note on Monday, November 18th. Finally, Wells Fargo & Company lowered their target price on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a report on Tuesday.

Check Out Our Latest Research Report on RXO

Institutional Investors Weigh In On RXO

A number of large investors have recently modified their holdings of the stock. FMR LLC lifted its holdings in RXO by 439.5% in the 3rd quarter. FMR LLC now owns 47,837 shares of the company’s stock worth $1,339,000 after buying an additional 38,970 shares in the last quarter. Primecap Management Co. CA lifted its stake in shares of RXO by 20.7% in the second quarter. Primecap Management Co. CA now owns 1,020,900 shares of the company’s stock worth $26,697,000 after acquiring an additional 175,300 shares in the last quarter. Citigroup Inc. boosted its holdings in RXO by 132.4% in the third quarter. Citigroup Inc. now owns 196,748 shares of the company’s stock valued at $5,509,000 after purchasing an additional 112,073 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in RXO by 7.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,068,380 shares of the company’s stock valued at $57,915,000 after purchasing an additional 136,886 shares in the last quarter. Finally, Driehaus Capital Management LLC purchased a new stake in RXO during the 2nd quarter worth approximately $19,965,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Trading Down 1.7 %

RXO stock opened at $25.30 on Friday. The stock has a market cap of $4.07 billion, a PE ratio of -12.78, a P/E/G ratio of 15.82 and a beta of 1.52. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.21. The stock has a 50-day moving average price of $27.36 and a 200 day moving average price of $27.83. RXO has a 52 week low of $18.75 and a 52 week high of $32.82.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $956.19 million. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.05 earnings per share. Equities research analysts predict that RXO will post 0.12 earnings per share for the current fiscal year.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.